| # | Drug | Count |
|---|---|---|
| 0 | DASATINIB | 173 |
| 1 | RITUXIMAB | 78 |
| 2 | PREDNISONE | 71 |
| 3 | CYCLOPHOSPHAMIDE | 61 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 61 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 61 |
| 6 | TACROLIMUS | 38 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 34 |
| 8 | TACROLIMUS OINTMENT 0.1% | 34 |
| 9 | FUROSEMIDE | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASATINIB | 173 | 0.0186 |
| 1 | ISRADIPINE | 5 | 0.0089 |
| 2 | REPOTRECTINIB | 2 | 0.0073 |
| 3 | URIDINE TRIACETATE | 1 | 0.0067 |
| 4 | ETHIODIZED OIL | 8 | 0.0062 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 6 | CAPMATINIB | 14 | 0.0059 |
| 7 | PORFIMER SODIUM | 2 | 0.0059 |
| 8 | RIFABUTIN | 10 | 0.0036 |
| 9 | DIMETICONE | 1 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 114 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 86 |
| 2 | Kinase Inhibitor [EPC] | 75 |
| 3 | Alkylating Drug [EPC] | 67 |
| 4 | Loop Diuretic [EPC] | 50 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 49 |
| 6 | Platinum-based Drug [EPC] | 48 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 43 |
| 8 | Microtubule Inhibitor [EPC] | 33 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 10 | 0.0029 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 18 | 0.0028 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 3 | Somatostatin Analog [EPC] | 17 | 0.0025 |
| 4 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 5 | Antimalarial [EPC] | 12 | 0.0011 |
| 6 | Antiprotozoal [EPC] | 12 | 0.0011 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 13 | 0.0010 |
| 8 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 9 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |